Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Apremilast generic entry?Kadcyla patent expiration date 2023?How long is the shortage of rytary expected to be?Is rytary going generoc anytime soon?Kadcyla extend expiry?
See the DrugPatentWatch profile for Vascepa
No. Vascepa (icosapent ethyl) is not fenofibrate. Vascepa is an omega-3 fatty acid prescription product, while fenofibrate is a different type of lipid-lowering medicine.
Vascepa (icosapent ethyl) is a prescription form of eicosapentaenoic acid (EPA), an omega-3 fatty acid. It is used to help lower triglycerides in people who need additional treatment beyond diet and other risk-reduction steps.
Fenofibrate is a fibrate medication. It works differently from omega-3 ethyl products and is also used to treat high triglycerides, but it is not the same drug class as Vascepa.
They can be prescribed in combination in some patients when a clinician decides the added lipid-lowering benefit outweighs risks and interactions. Whether that’s appropriate depends on your triglyceride level, other health conditions, and medications. If you tell me what you were prescribed (Vascepa dose and any other meds) and what your triglycerides or cholesterol results are, I can help you understand how they’re typically intended to fit together.
Other Questions About Vascepa :